No. Human studies are required before a peptide therapeutic strategy for S. aureus infections in humans is recommended.
Since broad-spectrum antimicrobial peptides (AMPs) destroy all bacteria they come into contact with, there is a higher chance that the microbiota will become ecologically unbalanced. Additionally, details about the validity of the research methodology and the statistical reliability of the in vitro experiment outcomes should be presented to treat S. aureus infections in humans with peptides.
learn more about S. aureus here
https://brainly.com/question/13981054
#SPJ4
